Altered iron metabolism as a target for ferroptosis induction in head and neck cancer

被引:0
|
作者
Jaewang Lee
Jong-Lyel Roh
机构
[1] CHA Bundang Medical Center,Department of Otorhinolaryngology
[2] CHA University,Head and Neck Surgery
[3] CHA University,Department of Biomedical Science, General Graduate School
来源
Cellular Oncology | 2023年 / 46卷
关键词
Iron; Labile iron pool; Ferroptosis; Regulators; Head and neck cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Iron is a mineral micronutrient essential for survival and vital functions in many biological processes in living organisms. Iron plays a crucial role as a cofactor of iron-sulfur clusters in energy metabolism and biosynthesis by binding with enzymes and transferring electrons to targets. Iron can also impair cellular functions by damaging organelles and nucleic acids by producing free radicals from redox cycling. Iron-catalyzed reaction products can induce active-site mutations in tumorigenesis and cancer progression. However, the boosted pro-oxidant iron form may contribute to cytotoxicity by increasing soluble radicals and highly reactive oxygen species via the Fenton reaction. An increased redox-active labile iron pool is required for tumor growth and metastasis, but the increased cytotoxic lipid radicals also lead to regulated cell death, such as ferroptosis. Therefore, this may be a major target for selectively killing cancer cells. This review intends to understand altered iron metabolism in cancers and discuss iron-related molecular regulators highly associated with iron-induced cytotoxic radical production and ferroptosis induction, focusing on head and neck cancer.
引用
收藏
页码:801 / 810
页数:9
相关论文
共 50 条
  • [31] The true value of altered fractionation in head and neck cancer
    Nuyts, Sandra
    LANCET ONCOLOGY, 2017, 18 (09): : 1147 - 1148
  • [32] Altered fractionated radiotherapy in head and neck cancer -: Reply
    Pignon, Jean-Pierre
    Le Maitre, Aurelie
    Sylvester, Richard
    Bourhis, Jean
    LANCET, 2006, 368 (9550): : 1868 - 1868
  • [33] Radiotherapy for cancer of the head and neck: altered fractionation regimens
    Nguyen, LN
    Ang, KK
    LANCET ONCOLOGY, 2002, 3 (11): : 693 - 701
  • [34] Modulators of Redox Metabolism in Head and Neck Cancer
    Chen, Xiaofei
    Mims, Jade
    Huang, Xiumei
    Singh, Naveen
    Motea, Edward
    Planchon, Sarah M.
    Beg, Muhammad
    Tsang, Allen W.
    Porosnicu, Mercedes
    Kemp, Melissa L.
    Boothman, David A.
    Furdui, Cristina M.
    ANTIOXIDANTS & REDOX SIGNALING, 2018, 29 (16) : 1660 - 1690
  • [35] Lipid metabolism reprogramming in head and neck cancer
    Liang, Jinfeng
    Li, Lin
    Li, Limei
    Zhou, Xiaoying
    Zhang, Zhe
    Huang, Yi
    Xiao, Xue
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [36] MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells
    Reinema, F. V.
    Hudson, N.
    Adema, G. J.
    Peeters, W. J. M.
    Neuzil, J.
    Stursa, J.
    Werner, L.
    Sweep, F. C. G. J.
    Bussink, J.
    Span, P. N.
    RADIOTHERAPY AND ONCOLOGY, 2024, 200
  • [37] Iron Metabolism and Ferroptosis in Epilepsy
    Chen, Shuang
    Chen, Yongmin
    Zhang, Yukang
    Kuang, Xi
    Liu, Yan
    Guo, Meiwen
    Ma, Lin
    Zhang, Daqi
    Li, Qifu
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [38] Targeting iron metabolism in breast cancer: Ferroptosis and genome stability
    Possemato, R. L.
    Sviderskiy, V. O.
    Alvarez, S. W.
    Terzi, E. M.
    CANCER RESEARCH, 2019, 79 (04)
  • [39] Role of dietary iron revisited: in metabolism, ferroptosis and pathophysiology of cancer
    Pandrangi, Santhi Latha
    Chittineedi, Prasanthi
    Chikati, Rajasekhar
    Lingareddy, Joji Reddy
    Nagoor, Meeravali
    Ponnada, Suresh Kumar
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (03): : 974 - 985
  • [40] Targeting ferroptosis for cancer therapy: iron metabolism and anticancer immunity
    Luo, Lianxiang
    Wang, Han
    Tian, Wen
    Zeng, Jiayan
    Huang, Yuru
    Luo, Hui
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (11): : 5508 - 5525